Since the survey of Bold and Browning (1975) , methods for protein-bound iodine have largely been replaced by competitive protein binding (CPB) and, latterly, by radioimmunoassay (RIA) methods for T4. This report analyses the performance of current thyroid function tests and digoxin assays in routine clinical practice over an 18-month period.
SUMMARY Initial experience of the Scottish Immunoassay Support Service Quality Control scheme for thyroxine (T4), triiodothyronine (T3), and digoxin is analysed.
For T4, radioimmunoassay (RIA) methods gave values close to the all-method mean. Competitive protein binding (CPB) kits gave values significantly higher (by 12~{;) in one and lower (by 10 %) in another, probably due to the extraction of interfering substances such as non-esterified fatty acids or thyroid hormone binding proteins. The range of between-batch precision of individual laboratories was 10,8-47,5~{; (mean 17·8 %) over the clinically relevant range. It was particularly poor at levels below the lower limit of the normal range.
For T3 RIA, kit methods gave significantly higher values than independent methods although recovery of exogenous T3 was approximately quantitative with both. Cross reaction of T4 in T3 assays was insignificant. The range of between-batch precision for individual laboratories was 11·4-35·5 % (mean 21·9 %), and was poorest at levels of I nmol/I or less.
For digoxin RIA, Lanoxitest y gave significantly higher values than other methods, and overrecovered exogenous digoxin. The range of between-batch precision was 13·8-35·2% (mean 21·6%), and was poorest at levels of 1 nmoljl or less.
The distribution of liquid human serum specimens at ambient temperature was satisfactory for quality control of T4, T3, and digoxin RIA but not for T4 by the Thyopac 4 method. Ox serum was unsuitable for certain T4 RIA methods. proteins and were Australia antigen negative. Sera were stored at -20°until despatched by first-class mail at ambient temperature. Concentrations of T4, T3, and digoxin were stable for the period of use of an individual pool (up to eight months) when stored at -20°. Laboratories were advised to store specimens frozen or at 4°until assay.
In recovery experiments, L-T3 (free acid), L-T4 (sodium salt pentahydrate), and digoxin, aU from Sigma Chemical Co, and L-T4 (free acid, T3 0·1 %)
The Inter-Area Quality Control Scheme started in from Henning Berlin GmBH, were dissolved in a September 1975as part of the Scottish Immunoassay small volume of ethanol before addition to serum Support Service. Between three and six coded pools. T4-, T3-, and digoxin-free sera and plasma specimens were circulated every two weeks from a were prepared by treatment with charcoal, according total of 17 pools, each pool being circulated from to the method of Larsen (1972) . five to 12 times each. Nine pools consisted of human Results greater than 3 SD from the method mean serum made available by the Blood Transfusion were excluded from calculation of method means Service, seven pools consisted of reconstituted dried and recoveries but were included in the assessment ACD plasma, and one pool was ox serum. These of precision. The methods used by the participating sera had normal levels of thyroid hormone binding laboratories are shown in Table 1 . 203
Results

BASELINE SECURITY
Each laboratory reported approximately six results on pools consisting of T4-, T3-, and digoxin-free plasma. Levels between 0·1 and 0'8 (mean 0,5) nmol/l were reported on one or more occasions by four of 10 laboratories.
Digoxin
Levels between 0·1 and 5'8 (mean 0,9) nmol{l were reported on one or more occasions by six of nine laboratories.
1'4
Undetectable levels were reported consistently by five of 18 laboratories, all using RIA methods. Five other laboratories using RIA, and all eight laboratories using CPB, reported the presence of T4 on at least one occasion. The mean level reported was 14 (range 1-55) nmol/l.°T Re = The Radiochemical Centre. tFor each laboratory, a between-batch precision was calculated from the CVs obtained from at least seven pools. The range of these CVs is shown in column 3 and the average of CVs for particular methods is shown in column 4.
An average of eight observations from individual laboratories provided the basis of calculating the CV for each pool.
For T4, the pools covered the range 41-205 nmolll; for T3, the range covered was 0-9-6'~nrnol/l; for digoxin, the range covered was 0,9-5,5 nmo1/1. The assessment of a laboratory's bias was based on the mean of at least five results reported for each of the 16 pools of human origin compared with the all-method mean for each pool.
No. of
T4
Laboratories using RIA methods reported levels averaging 98 % of the all-method mean (range 83-111%) with no significant variation related to separation technique. For laboratories using Thyopac 4, the mean level was significantly higher than the all-method mean (112%, range 103-132%; P< 0'001), but laboratories using Sta T4 reported lower mean levels (90%, range 75-107%; P < 0'001).
T3
Laboratories using kit methods reported values averaging 113% of the all-method mean (range 109-117%). This is significantly higher than by independent methods (p < 0'001).
Digoxin
Laboratories using Lanoxitest y reported values averaging 122% of the all-method mean (range 106-147%). This is significantly higher than by other methods (p < 0'001).
The accuracy of recovery of exogenous T4 and T3 added to a human serum pool is shown in Table 2 . Calculations are based upon three results per pool by each laboratory.
T4
The all-method mean recovery of T4 (Henning) was 90 % and T4 (Sigma) 99 %. Both CPB methods under-recovered compared to RIA methods.
T3
The all-method mean recovery of exogenous T3 (Sigma) was 96 %. Recoveries by kit and independent methods were similar. When exogenous T4 was added, recoveries ofT3 varied with the source ofT4. Thus, addition of Henning T4 at a concentration of 105 nmol{l and Sigma T4 at a concentration of 100 nmol/l increased the mean recovery of T3 by 0'1 and 0·5 nmol{l respectively. This suggests contamination of Sigma T4 with T3 (0'4 % by weight) rather than cross-reaction of exogenous T4 with T3 antisera.
The between-batch CY of individual laboratories ranged from 11·4 to 35·5 % (mean 21·9 %), with the majority between 20 and 30 %. One laboratory using solid phase and one using second antibody had much better precision (means 11'4 and 12·8 %). 
Digoxin
The all-method mean recovery of digoxin added to digoxin-free human serum was 114%. Lanoxitest 'Y kits gave significantly higher recoveries (mean 146 %) than other methods (mean 102 %). PRECISION (Tables 1 and 3)  T4 The between-batch precision of individual laboratories based on a minimum of five results from each of at least seven pools ranged from 10·8 to 47'5 % (mean 17·8 %). RIA methods gave marginally better precision than CPB methods (16,1 % v 21'1 %). Of laboratories with their own RIA methods, those using solid phase or second antibody separation techniques achieved better precision than those using PEG or charcoal.
The relationship between precision, T4 level (precision profile), and assay method is shown in Figure 1 . Precision was poorer for CPB than RIA methods at levels less than 70 nmol/l, The mean CY at a level of 41 nmol/I for Thyopac 4 was 52%, for Sta T4, 42·1 %, for RIA methods 20%.
The between-batch CY of individual laboratories ranged between 13'8 and 35'2% (mean 21'6%). Best . " The distribution of specimens of human, but not ox, serum at ambient temperature has proved satisfactory for the assessment of analytical control for T4, T3, and digoxin determined by radioimmunoassay. T4 by RIA was relatively unaffected by the conditions of specimen storage, confirming the findings of Seth et al. (1976) and Nye et al. (1975) . In the case of the Thyopac 4 assay, however, distribution of specimens that have previously been frozen and thawed is not satisfactory since we and others (Nye et al., 1975; Rootwelt, 1975) have shown that temperature and period of storage affect the T4 levels by this method. The excellent correlation between the apparent increase in T4 levels determined by Thyopac 4 and the increase in free fatty acids occurring during storage agrees with the findings of Liewendahl and Helenius (1976) , who suggested that the interference arose from ethanol-extracted fatty acids. T4 determined by Sta T4, another competitive protein binding assay, was unaffected by conditions of specimen storage; this method involves a silica-based extraction step, which may effectively exclude fatty acids.
In general, the Thyopac 4 method yielded values that were consistently higher than those by RIA methods. This is probably due in part to the conditions of handling the specimens already considered. In contrast, Sta T4 gave consistently lower values, which are due to the extraction of thyroid hormone binding proteins (Baird et al., 1978) . The recovery data suggest that the T4 RIA methods gave approximately quantitative recovery whereas both CPB methods recovered T4 incompletely. It is therefore suggested that the RIA method mean may be a closer approximation to the true value and that bias should be related to the RIA method mean rather than to the all-method mean.
None of the laboratories in the T4 scheme achieved better precision than was previously obtained in the automated assay of PBI (Bold and Browning, 1975) , and fewer than half had a mean between-batch CV of less than 15 %. The decline in precision at low T4 levels can be attributed in part to the poor precision given by Thyopac 4 and Sta T4. These preliminary results suggest that the CPB methods, Thyopac 4, and Sta T4 are no longer acceptable, particularly in situations in which specimens are at ambient temperature for more than a few hours, or where binding proteins are elevated. It should be noted that the Discussion Wendy A. Ratcliffe, F. C. Logue, and J. G. Ratcliffe P < 0'(01) and one RIA method with charcoal separation significantly lower levels (mean 50 ± 15·3 SD nmol/I; P < 0'(01) compared with the Thyopac 4 method (mean 88 ± 18'6 SD nmol/l) and the other RIA methods (mean 82'0 ± 9·0 SD nmolfl) . It was noted early in the scheme that the Thyopac 4 method gave markedly higher values than RIA methods when sample distribution was affected by postal delay of three days. To investigate this, we incubated aliquots of pooled serum at 4°, room temperature, and 37°for up to 15 days. T41evels were assayed in our laboratory by RIA, Thyopac 4, and Sta T4 methods, and non-esterified fatty acids by the method of Duncombe (1964) 1. No significant changes were found by RIA and Sta T4 methods. Thyopac 4 values also showed no change on storage at 4°but increased significantly on storage at room temperature and at 37°. After 15 days at room temperature, the Thyopac 4 values were 223 % of the initial value. At 37°, the rate of increase was accelerated, a 30% increase being observed after one day. There was a highly significant correlation between the increase in Thyopac 4 levels and the increase in non-esterified fatty acids (r = 0'96).
present study has employed sera with normal thyroid hormone binding protein levels, and further work is required to test the performance of methods for T4 and T3 in sera with abnormal binding protein levels. T3 kit methods gave significantly higher values than independently developed assays, though recoveries were comparable, suggesting that this may be due to differences in potencies of the reference standards. Evered et al. (1976) have also reported high values with a T3 kit (TRC). Cross reaction with T4 does not, however, appear to be a problem with the T3 assays studied. With digoxin, there was evidence that Lanoxitest y gave significantly higher values than the other methods and also overrecovered. The between-batch precision of T3 and digoxin methods is poorer than for T4, and the variation in results from many laboratories may give rise to misleading clinical interpretation.
Baseline security of all assays was, on the whole, acceptable, and reported levels were low where detectable. For T4, laboratories using CPB methods reported false-positive values for T4-free samples more commonly than laboratories using RIA methods. Several laboratories, particularly those using CPB methods, reported very low levels (eg, 1-10 nmol/l), which were clearly less than the reliable detection limit of the method. This suggests that such laboratories are unaware of the true detection limit (Ekins, 1976) . Poor precision at low concentrations is a problem affecting all the assays studied and is particularly important where these levels are of diagnostic significance, as with T4. The poor precision of the Thyopac 4 kit at borderline low levels has been discussed previously by Bold and Browning (1975) and attributed to the shallow doseresponse curve. The non-linearity of standard curves and the inadequate number of standards at high and low concentrations are also important defects encountered in certain kit methods.
The present analysis has clearly demonstrated that the routine standard of performance of T4, T3, and digoxin assays does not, in general, allow their full clinical potential to be realised since no laboratories achieved between-batch precision of less than 10% and, in more than half, the mean coefficients of variation were greater than 15 %. The study has, however, identified some of the problems associated with particular methods. Recognition of these factors is at least the first step in rectifying a situation in which 'some laboratories performing radioimmunoassays would be more usefully employed collecting random numbers, (Whitehead, 1977) .
